期刊文献+

冠心病合并2型糖尿病患者冠状动脉多支病变PCI与CABG术后5年随访 被引量:11

Follow-up for 5 years after percutaneous coronary intervention and coronary artery bypass grafting in patients with coronary multivessel lesions of coronary heart disease complicating type 2 diabetes mellitus
下载PDF
导出
摘要 目的:比较冠状动脉粥样硬化性心脏病(冠心病)合并2型糖尿病冠状动脉多支病变患者经皮冠状动脉介入治疗(PCI)置入药物涂层支架(DES)与冠状动脉旁路移植术(CABG)后远期疗效。方法连续入选2002年12月至2008年12月住院期间的冠心病合并2型糖尿病患者,并成功行择期血运重建的多支冠状动脉病变患者,分为CABG组(n=270),DES组(n=285)。随访5年,从术后30 d开始到5年止结束,随访包括全因死亡、心源性死亡、非致死性卒中、非致死性心肌梗死、心绞痛复发和再次血运重建的主要不良心脑血管事件(MACE)。结果入选患者随访率100%。CABG组与DES组两组间5年全因死亡率(1.11%vs.1.40%)、心源性死亡率(0%vs.0%)、非致死性卒中发生率(2.22%vs.2.81%)无统计学差异(P>0.05)。DES组非致死性心肌梗死发生率(3.15%)、心绞痛复发率(17.89%)、再次血运重建率(12.28%)均高于CABG组(分别为1.11,5.56%,0.74%),差异均有统计学意义(P<0.05-0.01)。结论多支冠状动脉病变合并2型糖尿病患者CABG与PCI治疗5年生存率无明显差异,但多支冠状动脉病变合并2型糖尿病患者DES支架置入远期心绞痛复发率、再次血运重建率,非致死性心肌梗死发生率高于 CABG组。 Objective To compare the long-term curative effects between implanting drug eluting stent (DES) during percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with coronary multivessel lesions of coronary heart disease (CHD) complicating type 2 diabetes mellitus (T2DM). Methods The patients with successful selective revascularization were chosen continuously from Dec. 2002 to Dec. 2008, and divided into CABG group (n=270) and DES group (n=285). All patients were followed up for 5 years from 30 d after the operation to the 5th year. The content of follow-up included major adverse cardiovascular events (MACE), such as all-cause mortality, cardiac death, non-fatal stroke, non-fatal myocardial infarction, angina recurrence and onemore revascularization.Results The follow-up rate was 100% in all patients. In 2 groups, 5-year all-cause mortality (1.11%vs. 1.40%), rate of cardiac death (0% vs. 0%) and incidence of non-fatal stroke (2.22%vs. 2.81%) had no statistical difference (P〉0.05). In DES group, incidence of non-fatal myocardial infarction (3.15%), angina recurrent rate (17.89%) and onemore revascularization rate (12.28%) were higher than those in CABG group (1.11, 5.56%, 0.74%, andP〈0.05-P〈0.01).Conclusion CABG and PCI have no significant difference in 5-year survival rate in patients with coronary multivessel lesions of CHD complicating T2DM, while long-term angina recurrent rate, onemore revascularization rate and incidence of non-fatal myocardial infarction are higher in DES group than those in CABG group.
出处 《中国循证心血管医学杂志》 2014年第6期683-686,共4页 Chinese Journal of Evidence-Based Cardiovascular Medicine
基金 全军十二五面上课题支持(CWS11J216)
关键词 冠心病 2型糖尿病 冠状动脉旁路移植术 经皮冠状动脉介入术 冠状动脉多支病变 药物洗脱支架 Coronary heart disease Type 2 diabetes mellitus Coronary artery bypass grafting Percutaneous coronary intervention Coronary multivessel lesions Drug eluting stent
  • 相关文献

参考文献11

  • 1Dibra A,Kastrati A,Mehilli J,et al. Paclitaxel-eluting or sirolimus- eluting stents to prevent restenosis in diabetic patients [J]. N Engl J Med,2005,353(7):663-70.
  • 2Degertekin M, Arampatzis CA, Lemos PA,et al. Very long sirolimus- eluting stent implantation for de novo coronary lesions[J]. Am J Cardiology,2004,93(7):826-9.
  • 3Park SJ,Kim YH,Lee BK,et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stentt implantation[J]. J Am Coil Cm'diol,2005,45(3):351-6.
  • 4Guyton RA. Coronary artery bypass is superior to drug eluting stents in muhivessel coronary artery disease[J]. Ann Thorac Surg,2006,81 (6): 1949-1957.
  • 5Bravata DM,Gienger AL,MeDonald KM,et al. Systematic review:thecomparative affectiveness of percutaneous coronaT interventions and coronary artery bypass graft surgery[J]. Ann Intern Med,2007,147(10):703-16.
  • 6Rodriguez AE,Baldij Femandez,et al. Five-year-follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERAC IlI )[J]. JAm Coll Cardiol,2005,46(4):582-8.
  • 7Serruys PW,Morice MC,Kappetein AP,et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease[l]. N Engl ] Med,2009,360(lO):961-72.
  • 8Greenberg D,Bakhai A,Neil N,et al. Modeling the impact of patient and lesion characteristics on the cost-effectiveness of drug-eluting stents (abstr)[J]. J Am Coil Cardiol,2003,41(Suppl A):538A.
  • 9Glaser R,Selzer F,Faxon DP,et al. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention[J]. Circulation,2005,111 (2):143-9.
  • 10Schwartz L,Bertolet M,Feit F,et al. Impact of completeness of revascularization on long-term cardiovascular outcomes in patients with type 2 diabetes mellitus:Results from the bypass angioplasty revascularization investigation 2 diabetes[J]. Circ Cardiovasc Interv,2012,5(2): 166-73.

同被引文献106

引证文献11

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部